1. HALTHCC as a novel tumor response metric in patients with hepatocellular carcinoma undergoing locoregional therapy while awaiting liver transplantation. (March 2018) Authors: Sasaki, K.; Firl, D.J.; Kimura, S.; McVey, J.; Fontan, F.; Hashimoto, K.; Yeh, H.; Miller, C.M.; Markmann, J.F.; Aucejo, N.F. Journal: HPB Issue: Volume 20(2018)Supplement 1 Page Start: S12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗